Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Interest Coverage Ratio: 2022-2025

Historic Interest Coverage Ratio for Arrowhead Pharmaceuticals (ARWR) over the last 3 years, with Sep 2025 value amounting to 2.03.

  • Arrowhead Pharmaceuticals' Interest Coverage Ratio rose 118.36% to 2.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.10, marking a year-over-year increase of 105.92%. This contributed to the annual value of 1.10 for FY2025, which is 105.92% up from last year.
  • According to the latest figures from Q3 2025, Arrowhead Pharmaceuticals' Interest Coverage Ratio is 2.03, which was up 129.94% from -6.79 recorded in Q2 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Interest Coverage Ratio ranged from a high of 17.62 in Q1 2025 and a low of -34.58 during Q2 2024.
  • In the last 3 years, Arrowhead Pharmaceuticals' Interest Coverage Ratio had a median value of -11.07 in 2024 and averaged -10.37.
  • In the last 5 years, Arrowhead Pharmaceuticals' Interest Coverage Ratio plummeted by 282.90% in 2024 and then spiked by 201.13% in 2025.
  • Quarterly analysis of 4 years shows Arrowhead Pharmaceuticals' Interest Coverage Ratio stood at -14.79 in 2022, then tumbled by 72.03% to -25.44 in 2023, then surged by 70.69% to -7.46 in 2024, then surged by 118.36% to 2.03 in 2025.
  • Its Interest Coverage Ratio stands at 2.03 for Q3 2025, versus -6.79 for Q2 2025 and 17.62 for Q1 2025.